Home
Steyaertlab
Engineering Nanobodies for Structural Biology, Molecular Pharmacology and Drug Discovery
We pioneered the use of Nanobodies in X-ray crystallography and cryo-EM, aiming at the highest hanging fruits in structural biology including membrane proteins, amyloidogenic proteins, and (transient) multiprotein complexes.
We engineer Nanobodies to be used as research tools in biotechnology and molecular pharmacology.
We discover Nanobodies that modulate the function of difficult targets to develop first-in-class drugs.
Jan Steyaert
Science Director
Full professor at the Vrije Universiteit Brussel
Director of the VIB-VUB center for Structural Biology since 2017
Founder of ConfoTerapeutics, 2015
VIB group leader since 1995
Postdoc at ILRI, Nairobi, Kenya, 1993-1994
PhD work at Plant Genetic Systems and the VUB, Belgium, 1991